Showing 1481-1490 of 2526 results for "".
- Results RNA Issues Voluntary Worldwide Recall of Lubrisine Eye Drops Due to Manufacturing Sterility Concerns and Undeclared Colloidal Silverhttps://modernod.com/news/results-rna-issues-voluntary-worldwide-recall-of-lubrisine-eye-drops-due-to-manufacturing-sterility-concerns-and-undeclared-colloidal-silver/2476230/Results RNA is voluntarily recalling Lubrisine Eye Drops to the healthcare practitioner, retail or consumer level. This product, in a recent FDA inspection, was found to be manufactured using practices that do not support its sterility and contained undeclared colloidal silver.
- Unum Poll Finds 40 Percent of Adults Spend 12+ Hours on Devices Each Dayhttps://modernod.com/news/unum-poll-finds-40-percent-of-adults-spend-12-hours-on-devices-each-day/2476235/It’s the time of year when many Americans resolve to eat healthier, get more exercise or save more money. But a new resolution in this digital-crazed culture should be to give your eyes a break from too much screen time. A recent poll by employee benefits company Unum found that 40 percent of U.S
- University of Dayton Researcher Named on Second Patent for Device to Provide Better Relief for Glaucoma Patientshttps://modernod.com/news/university-of-dayton-researcher-named-on-second-patent-for-device-to-provide-better-relief-for-glaucoma-patients/2479616/Khalid Lafdi, University of Dayton Wright Brothers Endowed Chair in Nanomaterials, was named on a second patent for a medical drainage device mainly for glaucoma patients that also could be used for drainage in the ears, brain, or chest or to provide access to larger veins or arteries, according
- Bayer to Cut 12,000 Jobs, Exit Vet Unit Amid Drag From Suitshttps://modernod.com/news/bayer-to-cut-12000-jobs-exit-vet-unit-amid-drag-from-suits/2479631/Bayer announced Thursday that it will cut around 1,250 jobs from its pharmaceutical division as part of a wider staff-reduction plan that will lead to the loss of about 12,000 positions from its global workforce of 118,200 employees by the end of 2021. The streamlining is part of an overhaul unde
- Warby Parker Eyewear Now Available to People Enrolled in UnitedHealthcare Medicare Advantage Planshttps://modernod.com/news/warby-parker-eyewear-now-available-to-people-enrolled-in-unitedhealthcare-medicare-advantage-plans/2479652/For the first time, Warby Parker is accepting Medicare insurance. The company’s designer prescription eyewear is available to approximately 2 million people enrolled in UnitedHealthcare Medicare Advantage plans, either online or at more than 80 Warby Parker stores nationwide, according to a
- Unum Finds Significant Number of Millennials Value Vision Insurancehttps://modernod.com/news/unum-finds-significant-number-of-millennials-value-vision-insurance/2479704/Employee benefits provider Unum finds the elimination of vision benefits could motivate more than a third (34 percent) of U.S. workers ages 25 to 34 to look for a new job. These results and other key findings were part of an online poll among 1,227 working U.S. adults conducted by Unum in July.</
- AAO: Unapproved Therapies Cause Significantly More Patient Injuries Than Reported by Cell Therapy Clinicshttps://modernod.com/news/aao-unapproved-therapies-cause-significantly-more-patient-injuries-than-reported-by-cell-therapy-clinics/2479716/A team of ophthalmologists went looking for scientific evidence in support of commercially available “cell therapy” for eye diseases. Not only did they find virtually none, they discovered a growing number of patients are being irreparably harmed by unapproved cell therapies, accordin
- Eyevance Pharmaceuticals Acquires Exclusive Rights to Commercialize Flarex in the United Stateshttps://modernod.com/news/eyevance-pharmaceuticals-acquires-exclusive-rights-to-commercialize-flarex-in-the-united-states/2479751/Eyevance Pharmaceuticals announced the acquisition of Flarex (fluorometholone acetate ophthalmic suspension) 0.1% from Novartis AG. Flarex, approved in the United States, is indicated for the treatment of steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea,
- First FDA-Approved Iris Prosthesis Now Available in the United Stateshttps://modernod.com/news/veo-ophthalmics-launches-customflex-artificialiris-in-the-united-states/2479835/VEO Ophthalmics announced the launch of the ‘Customflex ArtificialIris,’ the first iris prosthesis available in the United States. The surgically implanted device received FDA approval on May 30, 2018 for use in children and adults for the treatment of iris defects resulting from cong
- University of Toledo Chemists Discover How Blue Light Speeds Blindnesshttps://modernod.com/news/university-of-toledo-chemists-discover-how-blue-light-speeds-blindness/2479929/Blue light from digital devices and the sun transforms vital molecules in the retina into cell killers, according to optical chemistry research at The University of Toledo. The process outlined in the study, which was recently published in the journal